Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma

Part of paid clinical trials in La Jolla, California.

Sponsor
Scripps Clinic
Study ID
NCT00286416
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Double blind protocol treatment of 2/3 of the patients with omalizumab and 1/3 placebo administer for 4 months. Patients selected for the study must have both aspirin exacerbated respiratory disease and allergic asthma and rhinitis. They must also have completed aspirin desensitization and be taking aspirin on a daily basis for the treatment of AERD.

Key Dates

Start date
Jan 31, 2006
Status verified
Jan 2006
Completion
Jul 31, 2008

Study Design

Enrollment
60 participants
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Respiratory Index scores

Locations (1)

FacilityCityStateZIPSite coordinators
Scripps Clinic at Torrey PinesLa JollaCalifornia92037
Christine Decker-Hughes, RN
[email protected]
858-554-8653
Donald D Stevenson, MD
[email protected]
858-554-8614
Donald D Stevenson, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in La Jolla, CA

By condition
Asthma
By specialty
PulmonologyLung disease
By research site
Scripps Clinic at Torrey Pines· La Jolla, CA

Related Studies